ISRCTN64382660
进行中（未招募）
未知
SPCG-17 - Prostate Cancer Active Surveillance Trigger Trial (PCASTT)
ppsala University0 个研究点目标入组 2,000 人2016年9月20日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- ppsala University
- 入组人数
- 2000
- 状态
- 进行中（未招募）
- 最后更新
- 2年前
概览
简要总结
2019 Protocol article in http://dx.doi.org/10.1136/bmjopen-2018-027860 protocol (added 21/09/2020)
研究者
入排标准
入选标准
- •The inclusion criteria are:
- •1\. Recently (within 12 months) diagnosed adenocarcinoma of the prostate
- •2\. Tumour stage \= T2a, NX, M0 (former MX)
- •3\. PSA \<15 ng/ml, PSA density \= 0,2 ng/ml/cc
- •4\. Gleason pattern 3\+3\=6 (any number of cores, any cancer involvement) or Gleason pattern 3\+4\=7 (\<3 cores (or \<30 % of cores if more than ten cores are taken), \<10 mm cancer in one core)
- •5\. Life expectancy \>10 years with no upper age limit
- •6\. Candidate for curative treatment if progression occurs
- •7\. Signed written informed consent
排除标准
- •Participants not fulfilling the inclusion criteria
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
SPCG17: Prostate Cancer Active Surveillance Trigger TrialProstate CancerNCT02914873Uppsala University2,008
已完成
不适用
Prostate cancer screening trial using imagingISRCTN43502108Imperial College London408
招募中
2 期
Active surveillance for early prostate cancer: international study (PRIAS-JAPAN)JPRN-UMIN000002874Kagawa university1,400
暂停
不适用
How do waiting times during diagnosis affect psychological and physiological stress in men with suspected prostate cancer?ISRCTN45953686Örebro University Hospital400
招募中
不适用
The Active Surveillance StudyProstate CancerNCT05810467Institute of Cancer Research, United Kingdom200